Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 962 of 5804
-
Could a simple amino acid ease rare brain disorders?
Symptom relief Not yet recruitingA pivotal, randomized, double-blind, placebo-controlled, multi-center therapeutic study for patients age 4 and older with a confirmed diagnosis of CACNA1A. The objective of this study is to evaluate the safety, tolerability and efficacy of N-acetyl-L-leucine (IB1001) compared to …
Phase: PHASE3 • Sponsor: IntraBio Inc • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
New hope for IBD patients: can a better antibiotic stop c. diff for good?
Disease control Not yet recruitingThis is a randomized, double-blind study to assess the safety and efficacy of fidaxomicin compared to vancomycin for decolonization of C. difficile in IBD patients. A total of 60 patients who meet eligibility criteria will be randomized 1:1 to either the fidaxomicin or vancomycin…
Phase: PHASE4 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Experimental immune cell cocktail targets tough lymphoma
Disease control Not yet recruitingThis research study is for people who have relapsed or refractory B-cell non-Hodgkin's lymphoma (NHL) that has not responded to two or more lines of therapy. The purpose of this study is to identify the recommended dose of allogeneic NK cells in combination with IL-2, Tafasitamab…
Phase: PHASE1 • Sponsor: Paolo Caimi, MD • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Veterans' chronic back pain may be eased by natural brain molecules in new trial
Symptom relief Not yet recruitingChronic pain symptoms are very common among U.S. Military Veterans and have a profound negative impact on mental health symptoms and quality of life, in addition to increasing risk for suicidal ideation and suicidal behaviors. There are currently extremely few safe and effective …
Phase: PHASE2 • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
New combo therapy aims to prevent lung damage in tiniest preemies
Disease control Not yet recruitingThis clinical trial is being done to evaluate the safety and clinical response of late surfactant treatment with budesonide in extremely preterm infants requiring mechanical ventilation at 7-14 days of age.
Phase: PHASE1, PHASE2 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Could a diabetes drug curb ice addiction? new trial aims to find out
Disease control Not yet recruitingMethamphetamine use disorder is a major public health concern in Australia and globally. GLP-1 medications such as semaglutide (e.g. Ozempic) are approved for diabetes and medication, and may potentially affect craving for other substances apart from food. We do not know if this …
Phase: PHASE2 • Sponsor: Kirby Institute • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New study aims to improve COPD care by checking the heart too
Disease control Not yet recruitingThe goal of this randomized clinical trial is to learn whether a combined cardio-pulmonary assessment improves cardiac function, exercise capacity, cardiac biomarkers and health-related quality of life in adults with mild-to-moderate chronic obstructive pulmonary disease (COPD) w…
Phase: NA • Sponsor: University of Bari Aldo Moro • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New drug hopes to tame hardening skin disease
Disease control TerminatedThis study is designed to assess the safety and tolerability of the anti-human CCL24 monoclonal antibody CM-101 in adult patients with systemic sclerosis (SSc). Approximately 45 patients at approximately 40 sites will be randomized in a 2:1 ratio to receive either 10 mg/kg CM-101…
Phase: PHASE2 • Sponsor: ChemomAb Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Brain stent trial aims to ease pressure headaches and save sight
Disease control Not yet recruitingThe objective of this clinical investigation is to evaluate and demonstrate the clinical benefit, performance, and safety of the SILANCE Stent, which is specifically designed for the treatment of patients with symptomatic sinus stenoses associated with IIH.
Phase: NA • Sponsor: Acandis GmbH • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New strategy aims to get ventilator patients off breathing machines sooner
Disease control Not yet recruitingThe goal of this clinical trial is to learn whether a phenotype-guided weaning strategy can help adults with chronic comorbidities be liberated from invasive mechanical ventilation earlier. It will also learn about the safety of this strategy. The main questions it aims to answe…
Phase: NA • Sponsor: Southeast University, China • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New hope for teens with rare nerve disease: drug trial launches
Disease control Not yet recruitingThe main purpose of the study is to determine the correct dose of empasiprubart in adolescent participants. It also aims to evaluate if empasiprubart may work and how safe it is for the use in children living with CIDP. The study consists of an open label treatment phase where p…
Phase: PHASE2, PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Oxygen-Enhanced MRI could sharpen radiotherapy for deadly brain cancers
Diagnosis Not yet recruitingHigh-grade gliomas (HGGs) are the most common type of brain cancer in adults. Life expectancy for patients with HGGs is low. Radiotherapy aims to cure the tumour, but this is hard because HGGs are resistant to treatment. Among the possible causes of resistance may be tumour cells…
Phase: NA • Sponsor: The Leeds Teaching Hospitals NHS Trust • Aim: Diagnosis
Last updated Jul 02, 2026 00:00 UTC
-
Could a simple silver liquid stop Kids' tooth decay without drilling?
Disease control Not yet recruitingThis is a community-based, parallel-group, double-blinded randomised controlled trial aimed at evaluating the effectiveness of single and dual applications of 38% Silver Fluoride (SF) in arresting dentinal caries among Malaysian preschool children aged 4 to 6 years. The main que…
Phase: PHASE3 • Sponsor: University of Malaya • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Sleep drug could quiet breathing pauses in apnea
Disease control Not yet recruitingThe goal of this clinical trial is to investigate the 1-month treatment effects of different dose of lemborexant in moderate OSA adult patients (18-65 years of age) with low arousal threshold. The main questions it aims to answer are: Primary outcome measure: Apnea/hypopnea ind…
Phase: PHASE1, PHASE2 • Sponsor: Chulalongkorn University • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Shockwave therapy may ease stubborn achilles pain
Symptom relief Not yet recruitingBACKGROUND Achilles tendinopathy-pain in the Achilles tendon-is a common and often long-lasting condition that limits physical activity and performance, and also affects work capacity and quality of life. The pain is localized either to the mid- portion of the tendon or at its in…
Phase: NA • Sponsor: Vastra Gotaland Region • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
Scientists probe tumor environment to predict drug resistance in stomach cancer
Knowledge-focused Not yet recruitingSurgical resection remains the only curative option for resectable gastric cancer, but perioperative FLOT chemotherapy is associated with substantial rates of chemoresistance and recurrence, largely driven by marked tumor heterogeneity. Recent data from the MATTERHORN phase III t…
Sponsor: Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis • Aim: Knowledge-focused
Last updated Jul 11, 2026 00:00 UTC
-
Timing of bowel irrigation could ease life after rectal cancer surgery
Symptom relief Not yet recruitingThis study aims to evaluate the optimal timing of trans-anal irrigation (TAI) for participants with low anterior resection syndrome (LARS) who have undergone surgery for rectal cancer. The main question it aims to answer is: "Can starting TAI within three months of stoma closur…
Phase: NA • Sponsor: Simona Ascanelli • Aim: Symptom relief
Last updated Jul 12, 2026 00:00 UTC
-
Could trauma history sabotage epilepsy surgery? a new study investigates
Knowledge-focused Not yet recruitingWhy is this study being conducted? For people with drug-resistant focal epilepsy, surgery, to remove the part of the brain where seizures start, is currently the most effective treatment. In many people, especially those with temporal lobe epilepsy, surgery can stop seizures comp…
Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
Could a Once-Daily inhaler replace four daily doses for COPD attacks?
Disease control Not yet recruitingThe primary aim is to determine whether nebulized Formoterol twice daily plus Revefenacin once daily is non-inferior to standard-of-care nebulized Albuterol and Ipratropium therapy four times daily in relieving dyspnea among patients with ECOPD presenting to the ED and requiring …
Phase: PHASE4 • Sponsor: University of Tennessee Graduate School of Medicine • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Can a smart drug deliver a toxic payload directly to cancer cells?
Disease control Not yet recruitingThe goal of this clinical trial is to learn if ADC drug MC002 works to treat locally advanced/metastatic solid tumors in adults. It will also learn about the safety of MC002. The main questions it aims to answer are: Does participants tolerate the drug MC002 ? What medical probl…
Phase: PHASE1 • Sponsor: Hangzhou MacroLink Biopharmaceutical LLC • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC